This application seeks to renew an NICHD-sponsored National Research Service Award T32 that supports fellowship training in the Department of Pediatrics at the Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania (Penn). The long-term objective of the training program is to foster the development of pediatric investigators who are prepared to pursue independent academic careers examining important issues relevant to health and disease in children. The program will exploit the rich research and training resources at CHOP and Penn, including a cadre of faculty mentors in the Department of Pediatrics and other departments who are performing rigorous science in areas germaine to pediatrics, have a strong record of successful mentoring and collaboration, and have a strong record of extramural funding. Four trainees will be supported each year and will be drawn from subspecialty fellows in the Department of Pediatrics, with particular emphasis on recruitment of women, underrepresented minorities, individuals with disabilities, and other disadvantaged individuals. Trainees will generally receive support for two years of investigation and will emphasize the application of basic techniques, cutting edge bioinformatics approaches, and rigorous clinical and epidemiologic methods to improve our understanding of the processes that underlie pediatric diseases and to develop new and effective therapies for children. Trainees will have access to the full array of clinical and laboratory research cores and will benefit from the extensive educational activities at CHOP and Penn, including master degree programs, individual courses, journal clubs, and a range of seminars. The Principal Investigator/Program Director and the Training Director will receive assistance from an internal advisory committee and an external advisory committee to select candidate trainees, to review the scholarly progress of trainees, and to ensure the optimal operation of the program. The renewal of this T32 program will continue the tradition established during the past 17 years of the program, capitalizing on the tremendous strengths of CHOP as an academic pediatric institution and Penn as a leading research university, with an outstanding pool of subspecialty fellows, a large number of talented mentors, and numerous cutting edge research programs. CHOP and Penn provide a comprehensive, resource-intense environment and a proven track record of training academic investigators in basic, translational, and clinical research.
The overall goal of this NRSA-T32 program is to foster the development of pediatric investigators who are prepared to pursue independent academic careers examining important issues relevant to health and disease in children. We accomplish this goal by training outstanding pediatric fellows to become successful physician- scientists, addressing questions of fundamental importance to health and disease in children. Candidates for our program are enrolled in our subspecialty fellowship programs and are identified through national searches for talented pediatricians with signficant potential for success as physician-scientists, with particular emphasis on recruitment of women, underrepresented minorities, individuals with disabilities, and other disadvantaged individuals .
|Hill, David A; Leahy, Allison Barz; Sciasci, Joseph et al. (2018) Medication contaminants as a potential cause of anaphylaxis to vincristine. Pediatr Blood Cancer 65:|
|Henrickson, Sarah E; Walter, Jolan E; Quinn, Colin et al. (2018) Adult-Onset Myopathy in a Patient with Hypomorphic RAG2 Mutations and Combined Immune Deficiency. J Clin Immunol 38:642-645|
|Raje, Nikita; Snyder, Brenda L; Hill, David A et al. (2018) Severe immunodeficiency associated with acute lymphoblastic leukemia and its treatment. Ann Allergy Asthma Immunol 120:537-538.e1|
|Le Coz, Carole; Nolan, Brian E; Trofa, Melissa et al. (2018) Cytotoxic T-Lymphocyte-Associated Protein 4 Haploinsufficiency-Associated Inflammation Can Occur Independently of T-Cell Hyperproliferation. Front Immunol 9:1715|
|Ruffner, Melanie A; USIDNET Body Weight Group; Sullivan, Kathleen E (2018) Complications Associated with Underweight Primary Immunodeficiency Patients: Prevalence and Associations Within the USIDNET Registry. J Clin Immunol 38:283-293|
|Hill, David A; Leahy, Allison Barz; Sciasci, Joseph et al. (2018) Reply to: Medication contaminants as a potential cause of anaphylaxis to vincristine: What about drug specific antigens? Pediatr Blood Cancer 65:|
|Nelson, Victoria L; Nguyen, Hoang C B; Garcìa-Cañaveras, Juan C et al. (2018) PPAR? is a nexus controlling alternative activation of macrophages via glutamine metabolism. Genes Dev 32:1035-1044|
|Fahey, Lisa M; Guzek, Ryan; Ruffner, Melanie A et al. (2018) EMSY is increased and activates TSLP & CCL5 expression in eosinophilic esophagitis. Pediatr Allergy Immunol 29:565-568|
|Cianferoni, Antonella; Ruffner, Melanie A; Guzek, Ryan et al. (2018) Elevated expression of activated TH2 cells and milk-specific TH2 cells in milk-induced eosinophilic esophagitis. Ann Allergy Asthma Immunol 120:177-183.e2|
|Ding, Yang Y; Stern, Julie W; Jubelirer, Tracey F et al. (2018) Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure. Haematologica 103:e427-e431|
Showing the most recent 10 out of 48 publications